The store will not work correctly when cookies are disabled.
6-bromo-N-(4-methoxyphenyl)-2,6'-biimidazo[1,2-a]pyridin-3-amine
ID: ALA4537166
PubChem CID: 155548769
Max Phase: Preclinical
Molecular Formula: C21H16BrN5O
Molecular Weight: 434.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(Nc2c(-c3ccc4nccn4c3)nc3ccc(Br)cn23)cc1
Standard InChI: InChI=1S/C21H16BrN5O/c1-28-17-6-4-16(5-7-17)24-21-20(25-19-9-3-15(22)13-27(19)21)14-2-8-18-23-10-11-26(18)12-14/h2-13,24H,1H3
Standard InChI Key: ALCWUZVXBILNOR-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
43.1068 -12.3793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9381 -11.5728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1533 -11.3178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4989 -12.9337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7143 -12.6824 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.5387 -11.8670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7088 -11.7821 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.3716 -12.5451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9931 -13.1014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1452 -13.4192 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.5582 -12.1470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8925 -12.6342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.2283 -12.6342 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.9693 -13.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.5170 -14.0301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.3237 -13.8622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.5798 -13.0756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.0304 -12.4655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.5570 -11.3210 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.2716 -10.9069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.9844 -11.3203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.6985 -10.9069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.6977 -10.0801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.9768 -9.6684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.2656 -10.0841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.4118 -9.6651 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
48.1282 -10.0761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.3877 -12.9041 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
10 14 2 0
13 11 1 0
11 12 2 0
12 10 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
11 19 1 0
12 1 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
26 27 1 0
17 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 434.30 | Molecular Weight (Monoisotopic): 433.0538 | AlogP: 5.16 | #Rotatable Bonds: 4 |
Polar Surface Area: 55.86 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 6.39 | CX LogP: 3.72 | CX LogD: 3.68 |
Aromatic Rings: 5 | Heavy Atoms: 28 | QED Weighted: 0.42 | Np Likeness Score: -1.81 |
References
1. (2018) Inhibitors of trim33 and methods of use, |